US Corporate Board Director Changes SEC Filings — March 04, 2026

04-03-2026

FactSet announced the appointments of Kate Stepp as Chief AI Officer and Bob Stolte as Chief Technology Officer, effective March 2, 2026, to accelerate enterprise AI and platform strategy, with both reporting to CEO Sanoke Viswanathan. Kate Stepp previously served as CTO since September 2022, focusing on client-centric technology and AI expansion. These leadership changes reinforce FactSet's commitment to AI innovation, serving more than 9,000 global clients and 239,000 users across 19 countries.

• ·Kate Stepp held the role of Chief Technology Officer since September 2022.
• ·Appointments announced on March 4, 2026.

04-03-2026

On February 27, 2026, Timothy Go resigned from the Board of Directors of Celanese Corporation, effective as of that date. The resignation is not the result of any disagreement with the Company's operations, policies, or practices. The Board and Company expressed gratitude for Mr. Go’s service as a Director.

• ·Filing date: March 4, 2026
• ·Event reported date: February 27, 2026
• ·Registrant state of incorporation: Delaware
• ·Commission File Number: 001-32410
• ·IRS Employer Identification No.: 98-0420726

04-03-2026

Tivic Health Systems, Inc. (Nasdaq: TIVC) appointed Michael K. Handley as CEO effective March 4, 2026, succeeding Jennifer Ernst, who has led since the company's founding in 2016 and will continue supporting the transition. The leadership change supports a strategic pivot to late-stage immunotherapies and biopharma expansion via the Velocity Bioworks CDMO subsidiary. Handley brings over two decades of experience, including US approvals and commercialization of 17 products generating billions in revenue at Amgen and Genentech.

• ·Tivic founded in 2016; Annual Report on Form 10-K for year ended December 31, 2024, filed March 21, 2025.
• ·Velocity Bioworks is a wholly owned full-service CDMO subsidiary based in San Antonio, Texas.
• ·Entolimod™ is a TLR5 agonist in late-stage development for Acute Radiation Syndrome (ARS) under FDA’s Animal Rule.

04-03-2026

Crown Holdings, Inc. (NYSE: CCK) elected packaging industry executive Michael P. Doss to its Board of Directors, effective March 3, 2026, expanding the board to ten members. Doss, former President, CEO, and Director of Graphic Packaging Corporation (2016-2025), also serves as a director at Regal Rexnord Corporation since 2023. Chairman and CEO Timothy J. Donahue praised Doss's expertise in packaging, manufacturing, and governance.

• ·Announcement dated February 26, 2026.
• ·SEC 8-K filing date: March 04, 2026.
• ·Doss's prior roles at Graphic Packaging span 25+ years.

04-03-2026

Effective March 1, 2026, Kenichi Kumemoto departed as a director of Sekisui House U.S., Inc., without serving on any board committees at the time. On the same date, the Board appointed Fumie Yoshii as a new director, with no arrangements, relationships requiring disclosure, committee assignments, or material compensation tied to the appointment. The company filed this 8-K voluntarily, noting it no longer has SEC reporting obligations.

• ·The company is incorporated in Delaware with I.R.S. employer identification no. 84-0622967.
• ·Principal executive offices at 4350 South Monaco Street, Suite 500, Denver, Colorado 80237.
• ·No securities registered pursuant to Section 12(b) of the Act.

04-03-2026

CreditRiskMonitor.com, Inc. (CRMZ) announced the termination of Chief Accounting Officer David Reiner's position on February 27, 2026, with his last day being the same date. The company thanked Mr. Reiner for his service. The filing was signed by CEO and President Michael I. Flum on March 4, 2026.

04-03-2026

RemSleep Holdings Inc. (RMSL) reported the passing of founder Thomas Wood, its Chairman and CEO, on February 26, 2026, creating vacancies in those roles. Effective March 2, 2026, Anita Michaels was elected Chairman of the Board, Jeffrey Marshall was appointed CEO and Director with an employment agreement including up to 7% equity incentives, and Alexander Johnson was appointed Director. The transition emphasizes continuity with Michaels retaining interim financial oversight amid no immediate financial disruptions noted.

• ·Anita Michaels, 72, is Thomas Wood's sister and inherited his ownership including super voting preferred shares.
• ·Jeffrey Marshall, 48, founder of HPM Marketing LLC, will continue limited outside consulting.
• ·Alexander Johnson, 52, previously consulted for the Company on capital formation and governance.

04-03-2026

BillionToOne reported Q4 2025 total revenue of $96.1M, up 113% YoY from $45.1M, and full year 2025 revenue of $305.1M, up 100% YoY from $152.6M, driven by prenatal revenue growth of 99% in Q4 and 90% FY, and oncology surging 735% in Q4 and 748% FY. However, Clinical Trial Support and Other Services revenue declined 18% FY YoY to $3.1M, while operating expenses rose 56% in Q4 and 50% FY. The company achieved Q4 operating income of $10.3M (vs. $11.7M loss prior) and FY operating income of $16.0M (vs. $47.1M loss), raised 2026 revenue guidance to $430M-$445M (41-46% growth), and holds $496M in cash.

• ·Gross profit Q4 2025: $68.6M (71% margin) vs. $25.7M (57% margin) Q4 2024.
• ·FY 2025 gross margin: 68% vs. 53% in 2024.
• ·Q4 2025 net income available to common shareholders: $4.4M ($0.11 per diluted share) vs. net loss $11.5M ($1.13 per diluted share).
• ·FY 2025 net cash flow excluding IPO proceeds: $12.5M.
• ·Overall ASP Q4 2025: $561 vs. $382 Q4 2024 (+47%).
• ·New products launched: Red Blood Cell and Platelet Fetal Antigen NIPT in Feb 2026; Northstar PGx and Northstar Select CH in Q1 2026.
• ·Conference call: March 4, 2026 at 1:30pm PT / 4:30pm ET.

04-03-2026

Horizon Bancorp, Inc. announced the elimination of the Chief Administration Officer position at the company and its subsidiary Horizon Bank, effective March 31, 2026, leading to the departure of Mark E. Secor, Executive Vice President and Chief Administration Officer, to pursue other opportunities. The departure is not related to any disagreement on financial, accounting, or other matters. In connection, the company expects to provide Mr. Secor with severance of one week of pay per full year of service (maximum 13 weeks) based on his then-current weekly rate, plus a pro-rated 2026 Executive Officer Bonus at target, subject to a seven-day revocation period.

• ·Announcement made on March 3, 2026
• ·SEC filing dated March 4, 2026
• ·Includes customary general release of claims, non-disclosure, non-disparagement, and confidentiality covenants

04-03-2026

Insulet Corporation entered into a severance agreement and release with its former Chief Financial Officer, Ana M. Chadwick, on February 27, 2026. The agreement implements previously disclosed severance and post-termination benefits without any material changes or additional compensation terms. The filing was made on March 4, 2026, signed by Patricia K. Dolan, Vice President and Secretary.

• ·Severance Agreement references Company's Form 8-K filed September 16, 2025, Amended and Restated Executive Severance Plan filed April 28, 2025, and Confidentiality, Non-Solicit, Non-Compete, and IP Assignment Agreement dated April 7, 2024.
• ·Includes standard provisions for release of claims, mutual non-disparagement, and compliance with prior agreements.

04-03-2026

Resources Connection, Inc. (RGP) entered into a Separation and General Release Agreement with Chief Operating Officer Bhadreskumar Patel on March 3, 2026, with his last day of employment set for May 15, 2026. Patel will continue receiving his current salary through the separation date and is eligible for severance including a $1.65M lump sum (1.5x base salary plus target bonus), COBRA cost approximation for 18 months, and accelerated vesting of all unvested equity awards. The company does not plan to appoint a replacement COO, with business unit Presidents reporting directly to CEO Roger Carlile thereafter.

• ·Separation Agreement provides full term to exercise outstanding stock options
• ·Original Employment Agreement dated April 3, 2024
• ·Performance-based RSUs to vest at target level

04-03-2026

National Presto Industries reported 2025 net sales of $503.5M, up 29.7% YoY from $388.2M, primarily driven by a 42.9% increase ($121.9M) in Defense segment sales from higher backlog shipments, which also boosted Defense operating earnings 36.2% ($15.5M). However, net earnings fell 20.2% to $33.1M ($4.63 per share) from $41.5M ($5.82 per share), due to Housewares/Small Appliance segment sales declining 7.0% ($7.2M) and operating losses from Trump tariffs, distribution center relocation, and supplier bankruptcy. The Board declared a regular 2026 dividend of $1.00 per share with no extra dividend, while Safety segment showed modestly increased sales but still nominal with a reduced loss.

• ·Dividend record date: March 9, 2026; payment date: March 20, 2026
• ·82-year unbroken dividend history
• ·2026 annual shareholder meeting: May 19, 2026 (record date March 24, 2026)
• ·Safety segment: increased sales (nominal) and reduced comparative loss
• ·Tariffs treated as period costs under LIFO inventory method

04-03-2026

On March 4, 2026, the Board of Directors of Vir Biotechnology, Inc. appointed Marianne De Backer, M.Sc., Ph.D., MBA, the company's Chief Executive Officer and principal executive officer, to the additional position of President. There are no arrangements or understandings with other persons regarding the appointment, no family relationships with directors or executive officers, and no direct or indirect interests in transactions requiring disclosure under Item 404(a) of Regulation S-K. Biographical information for Dr. De Backer is incorporated by reference from the company's definitive proxy statement filed on April 17, 2025.

04-03-2026

On February 26, 2026, the Board of Directors of CoastalSouth Bancshares, Inc. appointed J. Simon Fraser as a director, effective immediately, with his term set to expire at the 2026 Annual Meeting of Stockholders, after which he is expected to join the Audit Committee and Nominating and Governance Committee. Mr. Fraser is determined to be an independent director under applicable SEC and NYSE standards. The appointment involves no arrangements with other persons, no family relationships, and only ordinary course loans from subsidiary Coastal States Bank.

• ·Loans to Mr. Fraser from Coastal States Bank were made in the ordinary course of business on substantially the same terms as comparable transactions with non-related persons, with no more than normal risk of collectability.
• ·No transactions between Mr. Fraser and the Company required to be reported under Item 404(a) of Regulation S-K, except the described loans.

04-03-2026

M/I Homes, Inc. announced that independent Director Norman L. Traeger has decided to retire from the Board upon the expiration of his term, having served since 1997. Chairman and CEO Robert H. Schottenstein commended Traeger's guidance, wisdom, and contributions to the company's success and growth. The announcement is neutral with no financial impacts disclosed.

• ·Company homebuilding operations in: Columbus and Cincinnati, Ohio; Indianapolis, Indiana; Chicago, Illinois; Minneapolis/St. Paul, Minnesota; Detroit, Michigan; Tampa, Sarasota, Fort Myers/Naples and Orlando, Florida; Austin, Dallas/Fort Worth, Houston and San Antonio, Texas; Charlotte and Raleigh, North Carolina; Nashville, Tennessee.

04-03-2026

Albemarle Corporation (NYSE: ALB) appointed Michelle T. Collins and Mark R. Widmar to its Board of Directors, effective February 26, 2026, as part of regular succession planning to enhance governance and long-term value creation. Collins, a former Vice Chair and Senior Audit Partner at Deloitte & Touche LLP with over 40 years of experience, will join the Audit & Finance Committee and Governance & Public Policy Committee. Widmar, CEO of First Solar since 2016, will join the Executive Compensation & Talent Development Committee and Safety, Sustainability, Operations & Capital Committee.

• ·Press release dated March 2, 2026; SEC filing dated March 4, 2026
• ·Collins served on Deloitte U.S. Board for six years as Vice Chair, Chair of Finance and Audit Committee, and Chair of Governance Committee
• ·Widmar previously CFO at First Solar, GrafTech (2006-2011), and held financial roles at NCR Inc. and Dell Inc.; career started at Ernst & Young in 1987

04-03-2026

Michael D. Lynch, Executive Vice President and Chief Financial Officer of AmeriServ Financial, Inc., announced his retirement after a long career of over 40 years, effective May 18, 2026. The company is conducting a search for his replacement. The filing was reported on March 4, 2026, and signed by Jeffrey A. Stopko, President and Chief Executive Officer.

• ·Company headquartered at Main and Franklin Streets, Johnstown, PA 15901
• ·Telephone: 814-533-5300
• ·Common Stock traded as ASRV on NASDAQ

04-03-2026

Johnson Outdoors Inc. announced on March 4, 2026, that David W. Johnson, its Vice President and Chief Financial Officer since November 2005, intends to retire later this year. The company has commenced a succession process to identify a successor, with Mr. Johnson expected to assist in the transition. His decision to retire is not due to any disagreement with the company's financial statements, reporting matters, or policies.

• ·Mr. Johnson has served as VP and CFO (principal financial and accounting officer) since November 2005.
• ·Company principal executive offices: 555 Main Street, Racine, Wisconsin 53403.

04-03-2026

Air T, Inc. entered into a new employment agreement with Tracy Kennedy, its Chief Financial Officer, effective February 27, 2026, providing a base salary of $331,000 per year, increasing to $360,000 effective January 1, 2027, and $397,000 effective January 1, 2028. The agreement includes eligibility for quarterly incentive compensation based on performance ratings (0% to 90%+ of quarterly base salary) and severance of up to 12 months of base salary upon termination without cause. No performance declines or flat metrics are mentioned in the filing.

• ·Employment is at-will with standard benefits, four weeks vacation, and restrictive covenants (non-competition, non-solicitation, non-disparagement, confidentiality).
• ·Quarterly incentives may be paused in cases of significant financial distress impacting debt obligations.
• ·Severance contingent on execution of general release of claims.

04-03-2026

DynaResource, Inc. approved the engagement of David Keough, an experienced mining executive, through his consulting firm Vulcan’s Forge Capital Pty. Ltd. to perform the functions of Chief Operating Officer, effective June 23, 2025. Compensation includes a $20,000 monthly consulting fee, 450,000 restricted stock units vesting in three equal annual installments starting August 12, 2025, and eligibility for an annual discretionary cash bonus up to 50% of prior year fees. The consulting agreement, dated February 26, 2026 but effective August 15, 2025, includes severance provisions for termination without cause.

• ·RSUs vest in three equal annual installments on the first three anniversaries of August 12, 2025 grant date.
• ·Termination without cause entitles Consultant to nine months of fees ($180,000) plus prorated bonus.
• ·Post-change in control termination without cause or for good reason entitles to 18 months of fees plus 18 months prorated bonus.

04-03-2026

Stellar V Capital Corp., a blank check company, elected Michael Braunstein as a class II director on February 28, 2026, to fill the vacancy left by his father Harry Braunstein, who passed away on November 2, 2025. Michael Braunstein, deemed independent under NASDAQ rules, will serve on the Audit Committee and Compensation Committee and chair the Nominating and Corporate Governance Committee. The appointment was recommended by the Nominating and Governance Committee.

• ·Michael Braunstein has been a partner of Braunstein Turkish LLP since September 2009 and managing member of Sunset Capital 1 LLC and affiliates since November 2025.
• ·From January 2024 to November 2025, Michael Braunstein was president of Sunset Capital 1 LLC and affiliates; from January 2019 to December 2023, vice president.
• ·Michael Braunstein holds a bachelor’s degree in music business from New York University (2004) and Juris Doctor from Brooklyn Law School (2009).

04-03-2026

On February 26, 2026, the Compensation Committee of Quanta Services, Inc.'s Board of Directors adopted the 2026 Incentive Plan, encompassing the annual incentive plan for corporate employees, long-term incentive plan for senior leadership, and discretionary plan for all employees. Executive officers and certain employees are eligible for cash, restricted stock units (RSUs), and/or performance stock units (PSUs) based on metrics such as EBITDA, EBITDA margin, and safety for annual awards, and return on invested capital (ROIC), earnings per share (EPS), and total stockholder return (TSR) for the January 1, 2026 to December 31, 2028 performance period. All equity awards will be issued under the Quanta Services, Inc. 2019 Omnibus Equity Incentive Plan, as amended.

• ·Awards governed by Exhibits 10.1 through 10.6, including term sheets and forms of PSU and RSU award agreements.
• ·Performance period for long-term incentives: January 1, 2026 through December 31, 2028.

04-03-2026

On February 26, 2026, Glen W. Herrick resigned immediately as director of MVB Financial Corp and MVB Bank, Inc., where he served as Chair of the Audit Committee and a member of the Finance Committee, citing concerns with the Company's corporate governance practices, executive compensation philosophy, and strategic focus. Cheryl Spielman, an existing Audit Committee member and qualified audit committee financial expert, was appointed as the new Chair of the Audit Committee. The resignation letter does not implicate any issues with financial statements, accounting, internal controls, or auditing.

• ·Resignation letter attached as Exhibit 17.1.
• ·Company provided disclosures to Mr. Herrick and will file any response letter from him as an amendment within two business days of receipt.
• ·Filing signed by Michael R. Sumbs on March 4, 2026.

04-03-2026

WesBanco, Inc.'s Board reduced its size from 19 to 15 directors effective after the April 2026 Annual Meeting, accepting voluntary retirements from Abigail M. Feinknopf, James W. Cornelsen, D. Bruce Knox, and Michael J. Crawford (the latter due to age policy), with no disagreements on company matters. Retiring directors received a one-time equity grant of restricted common stock valued at $250,000. To balance board classes, John L. Bookmyer and Joseph R. Robinson were reclassified and nominated for election at the 2026 Annual Meeting.

• ·Retirements and board size reduction effective at conclusion of 2026 Annual Meeting in April 2026.
• ·Bookmyer nominated for three-year term expiring 2029; Robinson for one-year term expiring 2027.
• ·Reclassifications of Bookmyer and Robinson solely for class balance; service deemed uninterrupted for committees and compensation.

04-03-2026

On February 26, 2026, Chui Tin Mok, an executive director on the Board of Faraday Future Intelligent Electric Inc., notified the Board of his intent to resign upon confirmation of a successor to focus on business execution in the UAE and Middle East. He will continue serving as an executive officer and Head of FF Middle East. The resignation has no immediate impact as no successor is yet named.

• ·Trading symbols: FFAI (Class A common stock), FFAIW (redeemable warrants) on Nasdaq Stock Market LLC
• ·Company confirmed as emerging growth company
• ·Business address: 18455 S. Figueroa Street, Gardena, CA 90248
• ·Former name: Property Solutions Acquisition Corp. (changed March 4, 2020)

04-03-2026

Alnylam Pharmaceuticals' Board granted CEO Yvonne Greenstreet a special performance-based equity award of 55,373 target performance share units valued at $18.0M based on the March 2, 2026 closing stock price of $325.07, vesting between 50% and 200% only if average stock price over a 30-day period in late 2029 reaches $500-$800 thresholds (54%-146% increases). Under her leadership, the company achieved nearly 100% stockholder return, met all 'Alnylam P5x25' goals including 2025 profitability, launched AMVUTTRA (including 2025 TTR cardiomyopathy approval), and advanced a pipeline with over 25 programs including three new Phase 3 trials. The award incentivizes achievement of 'Alnylam 2030' goals with full forfeiture if thresholds unmet.

• ·Special Award vesting measured by highest average closing price over 30 consecutive trading days in six months prior to December 31, 2029
• ·Award under Second Amended and Restated 2018 Stock Incentive Plan
• ·Full forfeiture if average stock price does not reach $500 threshold
• ·Form of award agreement to be filed in Q1 2026 10-Q

04-03-2026

InspireMD, Inc. provided notice of dismissal to Chief Operating Officer Andrea Tommasoli on February 27, 2026, effective with a six-month notice period under his French law-governed employment agreement with subsidiary InspireMD Ltd., dated November 2, 2020. Mr. Tommasoli is released from duties as of April 1, 2026, but will receive base salary through September 1, 2026, severance of approximately €61,000 gross, health benefits for up to 12 months, and accrued leave pay. The filing was signed by CEO Marvin Slosman.

• ·Employment Agreement dated November 2, 2020
• ·Common Stock, $0.0001 par value per share, trading as NSPR on Nasdaq Capital Market

04-03-2026

On February 26, 2026, Brown & Brown, Inc.'s Compensation Committee adopted the 2026 annual cash incentive plan for named executive officers with target amounts totaling $9.4M (J. Powell Brown $5.5M, R. Andrew Watts $1.4M, J. Scott Penny $1.1M, Chris L. Walker $1.4M), weighted 40% on organic revenue growth, 40% on adjusted EBITDAC margin, and 20% on personal objectives, with payouts ranging from 0-200%. On March 3, 2026, performance stock awards (PSA Shares) valued at $17.5M were granted to three executives under the 2019 Stock Incentive Plan (0-805% payout potential over five years from January 1, 2026), tied to share price CAGR, EPS growth (adjusted), and TSR vs. S&P 500 median; additionally, $1.5M in PSUs were granted to Chris L. Walker (0-299% payout). No historical performance data or changes were reported.

• ·Cash incentive payouts adjustable by Committee to exclude unusual items.
• ·PSA Shares vest in equal increments on March 3, 2032, 2033, 2034; PSUs on March 3, 2031-2033.
• ·Measurement period for PSA/PSUs: five years from January 1, 2026.
• ·Acceleration of vesting on death, disability, or CIC-related termination.
• ·Exhibits 10.1 (PSA Agreement) and 10.2 (PSU Agreement) filed.